drugset / Trial / NCT03891615
Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
This research study is studying a combination of drugs as a possible treatment for EGFR-Mutated Advanced Lung Cancer. The names of the study drugs involved in this study are Niraparib and Osimertinib.
Timeline
- Start
- 2019-06-06
- Primary completion
- 2022-04-30
- Completion
- 2024-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Niraparib | Small molecule | — | Oral |
| Subject | Osimertinib | Small molecule | — | Oral |